Detalles de la búsqueda
1.
The relationship between hepatitis B virus serum DNA, RNA and quantitative hepatitis B surface antigen, and the predictive value for mother-to-child transmission: an observational cohort study.
BJOG
; 129(2): 241-247, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455680
2.
[A 2020 update on the progress of treatment and new drug clinical trials for hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 29(2): 97-101, 2021 Feb 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33685074
3.
[Effect of aspirin on hepatocellular carcinoma and its related mechanism].
Zhonghua Gan Zang Bing Za Zhi
; 28(9): 799-802, 2020 Sep 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33053982
4.
[Clinical considerations in the design of clinical trial for innovative hepatitis B drugs].
Zhonghua Gan Zang Bing Za Zhi
; 28(8): 654-657, 2020 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-32911902
5.
[Systematic review of the methodology quality and reporting quality in colorectal cancer screening guidelines].
Zhonghua Yu Fang Yi Xue Za Zhi
; 53(4): 398-404, 2019 Apr 06.
Artículo
en Zh
| MEDLINE | ID: mdl-30982275
6.
[Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 27(11): 834-837, 2019 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-31941237
7.
[Research progress of lipolipomics in primary hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 27(10): 809-812, 2019 Oct 20.
Artículo
en Zh
| MEDLINE | ID: mdl-31734999
8.
[New serological markers as a monitoring indicator for clinical cure of chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 26(8): 565-567, 2018 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-30317786
9.
[HBV genotyping based on key epitopes of PreS1 antigen and its correlation with genotyping by full-length PreS1 sequencing].
Zhonghua Gan Zang Bing Za Zhi
; 26(5): 371-376, 2018 May 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29996206
10.
[Analysis of related factors for primary hepatic carcinoma caused by chronic hepatitis B and hepatitis C].
Zhonghua Yu Fang Yi Xue Za Zhi
; 51(6): 546-550, 2017 Jun 06.
Artículo
en Zh
| MEDLINE | ID: mdl-28592101
11.
[Hepatitis C-related hepatocellular carcinoma and the treatment with direct-acting antiviral agents].
Zhonghua Gan Zang Bing Za Zhi
; 25(12): 944-947, 2017 Dec 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29325299
12.
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C].
Zhonghua Gan Zang Bing Za Zhi
; 25(3): 187-194, 2017 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-28482405
13.
[Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].
Zhonghua Gan Zang Bing Za Zhi
; 25(8): 589-596, 2017 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-29056008
14.
[Recognize, disclose and manage conflicts of interest to protect academic integrity].
Zhonghua Gan Zang Bing Za Zhi
; 29(1): 3-4, 2021 01 20.
Artículo
en Zh
| MEDLINE | ID: mdl-33541015
15.
Tenofovir disoproxil fumarate vs adefovir dipivoxil in Chinese patients with chronic hepatitis B after 48 weeks: a randomized controlled trial.
J Viral Hepat
; 22(2): 85-93, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25243325
16.
Reversible phospho-Smad3 signalling between tumour suppression and fibrocarcinogenesis in chronic hepatitis B infection.
Clin Exp Immunol
; 176(1): 102-11, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24372395
17.
[Commitment to academic impartiality and independence to promote the healthy development of hepatology in China: joint comments from Chinese Journal of Hepatology, Journal of Clinical Hepatology, and Chinese Hepatology].
Zhonghua Gan Zang Bing Za Zhi
; 25(1): 3-4, 2017 Jan 20.
Artículo
en Zh
| MEDLINE | ID: mdl-28297770
18.
[Working together to promote the development of hepatology in China].
Zhonghua Gan Zang Bing Za Zhi
; 24(1): 2, 2016 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-26983382
19.
Epidemiological investigation of metabolic syndrome and analysis of relevant factors in north-eastern China.
J Int Med Res
; 38(1): 150-9, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20233524
20.
Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China.
J Hum Hypertens
; 29(1): 64-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24990419